The cost–effectiveness of point-of-care D-dimer tests compared with a laboratory test to rule out deep venous thrombosis in primary care

References

• White RH. The epidemiology of venous thromboembolism. Circulation 2003;107(90231):I-4-8
   Web of Science ®Google Scholar
• Goldhaber SZ. Preventing pulmonary embolism and deep vein thrombosis: a ’call to action’ for vascular medicine specialists. J Thromb Haemost 2007;5(8):1607-9
   PubMedGoogle Scholar
• Goodacre S, Sutton AJ, Sampson FC. Meta-analysis: the value of clinical assessment in the diagnosis of deep venous thrombosis. Ann Intern Med 2005;143(2):129-39
   PubMed Web of Science ®Google Scholar
• Buller HR, ten Cate-Hoek AJ, Hoes AW, et al. Safely ruling out deep venous thrombosis in primary care. Ann Intern Med 2009;150(4):229-35
   PubMed Web of Science ®Google Scholar
• Ten Cate-Hoek AJ, Toll DB, Buller HR, et al. Cost-effectiveness of ruling out deep venous thrombosis in primary care versus care as usual. J Thromb Haemost 2009;7(12):2042-9
   PubMedGoogle Scholar
• Geersing GJ, Janssen KJM, Oudega R, et al. Excluding venous thromboembolism using point of care D-dimer tests in outpatients: a diagnostic meta-analysis. BMJ 2009;339:b2880
   PubMedGoogle Scholar
• Di Nisio M, Squizzato A, Rutjes AWS, et al. Diagnostic accuracy of D-dimer test for exclusion of venous thromboembolism: a systematic review. J Thromb Haemost 2007;5(2):296-306
   PubMed Web of Science ®Google Scholar
• Stein PD, Hull RD, Patel KC, et al. D-Dimer for the exclusion of acute venous thrombosis and pulmonary embolism. Ann Intern Med 2004;140(8):589-602
   PubMedGoogle Scholar
• Baker PM, Howgate SJ, Atherton J, et al. Comparison of a point of care device against current laboratory methodology using citrated and EDTA samples for the determination of D-dimers in the exclusion of proximal deep vein thrombosis. Int J Lab Hematol 2010;32(5):477-82
   PubMedGoogle Scholar
• Legnani C, Fariselli S, Cini M, et al. A new rapid bedside assay for quantitative testing of D-Dimer (Cardiac D-Dimer) in the diagnostic work-up for deep vein thrombosis. Thromb Res 2003;111(3):149-53
   PubMedGoogle Scholar
• Bucek RA, Quehenberger P, Feliks I, et al. Results of a new rapid d-dimer assay (cardiac D-Dimer) in the diagnosis of deep vein thrombosis. Thromb Res 2001;103(1):17-23
   PubMedGoogle Scholar
• Dempfle CE, Korte W, Schwab M, et al. Sensitivity and specificity of a quantitative point of care D-dimer assay using heparinized whole blood, in patients with clinically suspected deep vein thrombosis. Thromb Haemost 2006;96(1):79-83
   PubMedGoogle Scholar
• Gardiner C, Pennaneac’h C, Walford C, et al. An evaluation of rapid D-dimer assays for the exclusion of deep vein thrombosis. Br J Haematol 2005;128(6):842-8
   PubMedGoogle Scholar
• Larsen TB, Stoffersen E, Christensen CS, et al. Validity of D-dimer tests in the diagnosis of deep vein thrombosis: a prospective comparative study of three quantitative assays. J Intern Med 2002;252(1):36-40
   PubMedGoogle Scholar
• Cini M, Legnani C, Cavallaroni K, et al. A new rapid bedside assay for D-dimer measurement (Simplify D-dimer) in the diagnostic work-up for deep vein thrombosis. J Thromb Haemost 2003;1(12):2681-3
   PubMedGoogle Scholar
• Subramaniam RM, Heath R, Cox K, et al. Does an immunochromatographic D-dimer exclude acute lower limb deep venous thrombosis? Emerg Med Australas 2006;18(5-6):457-63
   PubMedGoogle Scholar
• Neale D, Tovey C, Vali A, et al. Evaluation of the Simplify d-dimer assay as a screening test for the diagnosis of deep vein thrombosis in an emergency department. Emerg Med J 2004;21(6):663-6
   PubMedGoogle Scholar
• Emanuel EJ, Fuchs VR. The perfect storm of overutilization. JAMA 2008;299(23):2789-91
   PubMed Web of Science ®Google Scholar
• Owens DK, Qaseem A, Chou R, et al. High-value, cost-conscious health care: concepts for clinicians to evaluate the benefits, harms, and costs of medical interventions. Ann Intern Med 2011;154:174-80
   PubMed Web of Science ®Google Scholar
• Moons KGM. Criteria for Scientific Evaluation of Novel Markers: A Perspective. Clin Chem 2010;56:537-41
   PubMed Web of Science ®Google Scholar
• Reilly BM, Evans AT. Translating clinical research into clinical practice: impact of using prediction rules to make decisions. Ann Intern Med 2006;144:201-209
   PubMed Web of Science ®Google Scholar
• Schaafsma JD, van der Graaf Y, Rinkel GJE, et al. Decision analysis to complete diagnostic research by closing the gap between test characteristics and cost-effectiveness. J Clin Epidemiol 2009;62:1248-52
   PubMed Web of Science ®Google Scholar
• Geersing GJ, Toll DB, Janssen KJ, et al. Diagnostic accuracy and user-friendliness of 5 point-of-care D-dimer tests for the exclusion of deep vein thrombosis. Clin Chem 2010;56(11):1758-66
   PubMed Web of Science ®Google Scholar
• Briggs A, Sculpher M. An introduction to Markov modelling for economic evaluation. Pharmacoeconomics 1998;13(4):397-409
   PubMed Web of Science ®Google Scholar
• Sonnenberg FA, Beck JR. Markov models in medical decision making: a practical guide. Med Decis Making 1993;13(4):322-38
   PubMed Web of Science ®Google Scholar
• Heit JA. Venous stasis syndrome: the long-term burden of deep vein thrombosis. Hosp Med 2003;64(10):593-8
   PubMedGoogle Scholar
• Kahn SR, Ginsberg JS. Relationship between deep venous thrombosis and the postthrombotic syndrome. Arch Intern Med 2004;164(1):17-26
   PubMed Web of Science ®Google Scholar
• Statistics Netherlands. Doodsoorzaken; korte lijst (belangrijke doodsoorzaken), leeftijd, geslacht. Statistics Netherlands. 2011. Available from: http://statline.cbs.nl/StatWeb/publication/?DM=SLNL&PA=7052_95&D1=a&D2=a&D3=0&D4=0,41,51,l&HDR=G2,G1,G3&STB=T&VW=T
   Google Scholar
• Kind P, Hardman G, Macran S. UK Population Norms for EQ-5D. Centre for Health Economics; University of York: 1999
   Google Scholar
• van Dongen CJ. Chapter 7. An Evidence Based Approach to Optimizing Anticoagulant Strategies. Thesis CJ van Dongen. Amsterdam 2004
   Google Scholar
• Statistics Netherlands. Consumentenprijzen; prijsindex 2006=100. Den Haag/Heerlen.: statistics Netherlands. 2011. Available from: http://statline.cbs.nl/StatWeb/publication/default.aspx?DM=SLNL&PA=71311ned&D1=0-1%2c4-5&D2=0&D3=213-252&HDR=G1%2cT&STB=G2&VW=T [Last accessed on Sept 2014]
   Google Scholar
• Oostenbrink J, Bouwmans C, Koopmanschap M, et al. Dutch Cost Manual (in Dutch). Amstelveen: College voor Zorgverzekeringen, 2004
   Google Scholar
• Genees- en Hulpmiddelen Informatie Project (GIP databank). Diemen: health Care Insurance Board. Available from: www.gipdatabank.nl [cited 2011]
   Google Scholar
• Hakkaart- van Roijen L, Tan SS, Bouwmans CAM: Handleiding voor kostenonderzoek: Methoden en standaard kostprijzen voor economische evaluaties in de gezondheidszorg. Rotterdam: College voor zorgverzekeringen; 2010
   Google Scholar
• Barton GR, Briggs AH, Fenwick EA. Optimal cost-effectiveness decisions: the role of the cost-effectiveness acceptability curve (CEAC), the cost-effectiveness acceptability frontier (CEAF), and the expected value of perfection information (EVPI). Value Health 2008;11(5):886-97
   PubMed Web of Science ®Google Scholar
• Pink J, Lane S, Pirmohamed M, et al. Dabigatran etexilate versus warfarin in management of non-valvular atrial fibrillation in UK context: quantitative benefit-harm and economic analyses. BMJ 2011;343:d6333
   PubMed Web of Science ®Google Scholar
• Douketis JD, Gu CS, Schulman S, et al. The risk for fatal pulmonary embolism after discontinuing anticoagulant therapy for venous thromboembolism. Ann Intern Med 2007;147(11):766-74
   PubMed Web of Science ®Google Scholar
• Murin S, Romano PS, White RH. Comparison of outcomes after hospitalization for deep venous thrombosis or pulmonary embolism. Thromb Haemost 2002;88(3):407-14
   PubMed Web of Science ®Google Scholar
• Douketis JD, Kearon C, Bates S, et al. Risk of fatal pulmonary embolism in patients with treated venous thromboembolism. JAMA 1998;279(6):458-62
   PubMed Web of Science ®Google Scholar
• Prandoni P, Noventa F, Ghirarduzzi A, et al. The risk of recurrent venous thromboembolism after discontinuing anticoagulation in patients with acute proximal deep vein thrombosis or pulmonary embolism. A prospective cohort study in 1,626 patients. Haematologica 2007;92(2):199-205
   PubMed Web of Science ®Google Scholar
• Prandoni P, Lensing AW, Cogo A, et al. The long-term clinical course of acute deep venous thrombosis. Ann Intern Med 1996;125(1):1-7
   PubMed Web of Science ®Google Scholar
• Nieto JA, Solano R, Ruiz-Ribo MD, et al. Fatal bleeding in patients receiving anticoagulant therapy for venous thromboembolism: findings from the RIETE registry. J Thromb Haemost 2010;8(6):1216-22
   PubMed Web of Science ®Google Scholar
• Gibson NS, Schellong SM, Kheir DY, et al. Safety and sensitivity of two ultrasound strategies in patients with clinically suspected deep venous thrombosis: a prospective management study. J Thromb Haemost 2009;7(12):2035-41
   PubMedGoogle Scholar
• Caprini JA, Botteman MF, Stephens JM, et al. Economic burden of long-term complications of deep vein thrombosis after total hip replacement surgery in the United States. Value Health 2003;6(1):59-74
   PubMed Web of Science ®Google Scholar
• Bergman L, van der Meulen JH, Limburg M, et al. Costs of medical care after first-ever stroke in The Netherlands. Stroke 1995;26(10):1830-6
   PubMedGoogle Scholar